About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Characterization and Pathogenesis of ACLF

NCT04975490·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Jonel Trebicka, MD, PhD
CONTACT
+4963014256 [email protected]

Lead

Johann Wolfgang Goethe University Hospital

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Liver cirrhosis

You may not be if

extrahepatic and metastatic malignancy,
refusal for participation
decision of attending phycisian

The record

StatusUnknown

PhaseNo phase

Taking part1,000

StartedDec 2020

UpdatedJul 29, 2021

Conditions

Liver Cirrhosis Acute-On-Chronic Liver Failure Portal Hypertension

Where1

Translational Hepatology
Frankfurt am Main, Hesse, Germany

Clareo Health | Characterization and Pathogenesis of ACLF